{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:06:19Z","timestamp":1791648379337,"version":"4.3.4"},"reference-count":26,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T00:00:00Z","timestamp":1196294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare the efficacy of adalimumab versus placebo in reducing spinal and sacroiliac (SI) joint inflammation, by magnetic resonance imaging (MRI) in patients with active ankylosing spondylitis (AS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a randomized, multicenter, double\u2010blind, placebo\u2010controlled study. Patients (n = 82) received 40 mg adalimumab or placebo every other week during an initial 24\u2010week double\u2010blind period. MRIs of both the spine and SI joints were obtained at baseline, week 12, and week 52. Spinal and SI joint inflammation were measured using the Spondyloarthritis Research Consortium of Canada (SPARCC) MRI index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The spine SPARCC score in placebo\u2010treated patients increased by a mean of 9.4% from baseline, compared with a mean decrease of 53.6% in adalimumab\u2010treated patients (<jats:italic>P<\/jats:italic> &lt; 0.001); the SI joint SPARCC score decreased by a mean of 12.7% from baseline in placebo\u2010treated patients and by 52.9% in adalimumab\u2010treated patients (<jats:italic>P<\/jats:italic> = 0.017). The response in adalimumab\u2010treated patients was maintained at week 52. Placebo\u2010treated patients were switched to open\u2010label adalimumab treatment at week 24 and experienced similar reductions in spinal and SI joint inflammation by week 52. Similar large reductions in the spine and SI joint SPARCC scores were noted, even in patients who failed to meet the ASsessment in Ankylosing Spondylitis (International Working Group) criteria (nonresponders) at 12 weeks. In adalimumab\u2010treated patients, a reduced C\u2010reactive protein concentration at week 12 was significantly associated with improvement in the spine SPARCC score (<jats:italic>P<\/jats:italic> = 0.018).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Adalimumab significantly reduced both spinal and SI joint inflammation in patients with active AS after 12 weeks of treatment, and these improvements were maintained for up to 52 weeks.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.23044","type":"journal-article","created":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T17:16:33Z","timestamp":1196356593000},"page":"4005-4014","source":"Crossref","is-referenced-by-count":221,"title":["Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double\u2010blind, placebo\u2010controlled study"],"prefix":"10.1002","volume":"56","author":[{"given":"Robert G. W.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proton","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen T. D.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Choquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Maksymowych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,11,29]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780331202"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029298"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10883"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21337"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21445"},{"key":"e_1_2_8_7_2","first-page":"2050","article-title":"Scoring sacroiliac joints by magnetic resonance imaging: a multiple\u2010reader reliability experiment","volume":"32","author":"Landewe RB","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_8_8_2","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers M","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_8_9_2","first-page":"862","article-title":"Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment","volume":"34","author":"Lukas C","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21913"},{"key":"e_1_2_8_11_2","first-page":"S217","article-title":"Efficacy of adalimumab in active ankylosing spondylitis (AS): results of the Canadian AS Study","volume":"52","author":"Maksymowych WP","year":"2005","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21563"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_2_8_14_2","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20790"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22103"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22627"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"e_1_2_8_20_2","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index","volume":"21","author":"Jenkinson TR","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/009286150303700105"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21588"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20977"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032441"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21790"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei046"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.23044","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.23044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:22:10Z","timestamp":1692555730000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.23044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,29]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1002\/art.23044"],"URL":"https:\/\/doi.org\/10.1002\/art.23044","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,29]]}}}